Market Overview

Albany Molecular Research, Inc. (NASDAQ: )

0.00 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2017
Pre-Market
EPS:
REV:
0.07
105.579M
0.12
161.45M
0.13
163.822M
8.33%
1.47%
Q4 2016
Pre-Market
EPS:
REV:
0.4
126.412M
0.48
221.3M
0.34
191.322M
-29.17%
-13.55%
Q3 2016
Pre-Market
EPS:
REV:
0.14
104.579M
0.13
160.75M
0.17
152.738M
3076.92%
-498.41%
Q2 2016
Pre-Market
EPS:
REV:
0.22
89.548M
0.32
123.1M
0.36
120.81M
12.5%
-1.86%
Q1 2016
Pre-Market
EPS:
REV:
0.2
81.8M
0.21
107.2M
0.07
105.579M
-66.67%
-1.51%
Q4 2015
Pre-Market
EPS:
REV:
0.28
86.6M
0.36
133.4M
0.4
126.412M
11.11%
-5.24%
Q3 2015
Pre-Market
EPS:
REV:
-0.02
62.47M
0.13
95.15M
0.14
104.579M
7.69%
9.91%
Q2 2015
Pre-Market
EPS:
REV:
0.22
68.18M
0.19
85M
0.22
89.548M
15.79%
5.35%
Q1 2015
Pre-Market
EPS:
REV:
0.16
59.3M
0.15
81.5M
0.2
81.8M
33.33%
0.37%
Q4 2014
Pre-Market
EPS:
REV:
0.222
67.12M
0.33
91.9M
0.28
86.6M
-15.15%
-5.77%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!